Ebb Therapeutics, Inc.

Ebb Therapeutics, Inc. specializes in innovative sleep enhancement technologies, focusing on solutions that regulate temperature and monitor sleep patterns to improve overall sleep quality. Ebb Therapeutics, Inc. was founded in 2008 and is headquartered in Pittsburgh, US.

The company develops sleep solutions that aim to enhance the quality of sleep for individuals. In December 2020, Ebb Therapeutics raised USD 37 mn in venture funding led by KKR, bringing the total amount raised to USD 37 mn. The firm has executed a total of 4 deals since its inception. Ebb Therapeutics develops innovative sleep enhancement products, including flagship offerings such as the Chilipad Dock Pro, Chilipad Cube, and Sleep Tracker, designed to optimize sleep through temperature regulation and monitoring.

These products address common sleep issues like overheating and the need for personalized sleep environments, utilizing water-circulation technology and providing insights into sleep patterns for a diverse customer base across North America, Europe, and parts of Asia. Ebb Therapeutics generates revenue through a direct-to-consumer model via its e-commerce platform, allowing customers to purchase individual units such as the Chilipad Dock Pro and Chilipad Cube, as well as subscription options for the Sleep Tracker service. The pricing structure reflects the premium nature of their products, catering to various customer needs and budgets. Revenue streams also include partnerships with wellness retailers to enhance market reach.

Following the recent funding round in December 2020, Ebb Therapeutics plans to utilize the raised USD 37 mn to accelerate the development of new sleep enhancement products. The company is targeting expansion into new geographic markets, with specific plans to enhance its presence in Europe and Asia over the next two years. This strategic focus aims to broaden its customer base and enhance its market share in the evolving wellness industry.